Top Abstract Purchase Related
Home
>
Node
>
Subnode

Disordered cell-receptor metabolism (R-proteins) and the immunity indices in patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma

Faradzhev, Z.G.; Samsonov, V.A.; Bukhova, V.P.

Vestnik Dermatologii i Venerologii 10: 17-20

1990

ISSN/ISBN: 0042-4609
PMID: 2177582
Document Number: 367608
Elevated blood serum concentrations of R protein were revealed in the patients with malignant lymphomas of the skin and with Kaposi's sarcoma. In both conditions the level of R protein was elevated as against the norm and related to some cellular and humoral immunity parameters. Measurement of R protein concentrations and of the levels of some cellular and humoral immunity parameters in malignant lymphomas of the skin and Kaposi's sarcoma evidence a prognostic value of R proteins.

Document emailed within 1 workday
Secure & encrypted payments

Santón Roldán, A.; De San José, S.; Gómez Sanz, E.; Fernández Muñoz, R.; Herrera, P.; Bellas Menéndez, C. 2002: Human herpesvirus-8 detection in Kaposi's sarcoma, multiple myeloma, and lymphoproliferative syndromes occurring in immunocompetent and immunocompromised patients Medicina Clinica 119(7): 241-244
Warmuth, I.; Moore, P.S. 1997: Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. what is the current evidence for causality? Archives of Dermatology 133(1): 83-85
Gorshkova, N.I.; Samsonov, V.A.; Mazina, N.M.; Parastaev, S.A. 1989: Dynamics of immunologic indices in patients with Kaposi's sarcoma during treatment with the preparation leakadine Vestnik Dermatologii i Venerologii 9: 6-10
Stein, M.E.; Spencer, D.; Ruff, P. 1994: Lymphoproliferative malignancies in association with endemic African Kaposi's sarcoma Central African Journal of Medicine 40(7): 176-178
Guo, W.X.; Gill, P.S.; Antakly, T. 1995: Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation Cancer Research 55(4): 823-829
Murakami-Mori, K.; Mori, S.; Bonavida, B.; Nakamura, S. 1999: Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells Journal of Immunology 162(6): 3672-3679
Murakami-Mori, K.; Mori, S.; Taga, T.; Kishimoto, T.; Nakamura, S. 1997: Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation Journal of Immunology 158(11): 5518-5526
Faradzhev, Z.G.; Samsonov, V.A.; Bassalyk, L.S.; Nemtsova, M.P. 1989: The effectiveness of treating patients with malignant skin lymphoma and Kaposi's sarcoma studied via polyamines Vestnik Dermatologii i Venerologii 11: 20-25
Parfenova, T.M.; Morozov, V.A.; Il'in, K.V.; Chistiakova, I.A.; Samsonov, V.A.; Averina, A.V.; Kakezaĭ, I.A.; Bykovskiĭ, A.F. 1994: Detection of markers of the human T-cell leukemia virus in patients with T-cell lymphoma and Kaposi's sarcoma Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 5: 13-17
Olsen, S.J.; Chang, Y.; Moore, P.S.; Biggar, R.J.; Melbye, M. 1998: Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 Aids 12(14): 1921-1925
Kalamkarian, A.A. 1988: Principles of the current therapy of malignant lymphomas of the skin (mycosis fungoides, primary reticulosis, reticulosarcomatosis of the skin) and Kaposi's sarcoma Vestnik Dermatologii i Venerologii 2: 4-10
Pogozheva, A.V.; Tutel'ian, V.A.; Gapparova, K.M.; Trushina, E.N.; Miagkova, M.A. 2000: The effect of an antiatherosclerotic diet including omega-3 polyunsaturated fatty acids of marine and plant origins on the indices of cellular and humoral immunity in patients with ischemic heart disease and a disordered carbohydrate tolerance Voprosy Pitaniia 69(4): 33-35
Weninger, W.; Partanen, T.A.; Breiteneder-Geleff, S.; Mayer, C.; Kowalski, H.; Mildner, M.; Pammer, J.; Stürzl, M.; Kerjaschki, D.; Alitalo, K.; Tschachler, E. 1999: Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells Laboratory Investigation; A Journal of Technical Methods and Pathology 79(2): 243-251
Malysheva, M.V.; Bulycheva, T.I.; Deĭneko, N.L.; Samoĭlova, R.S.; Kaplanskaia, I.B.; Magoulas, C.; Zatsepina, O.V. 2010: The levels of key nucleolar proteins in the lymphoid cells of healthy individuals and patients with lymphoproliferative diseases Klinicheskaia Laboratornaia Diagnostika 12: 23-27
Zhang, X-ming.; Tang, M.; Liang, Q-chun. 2002: A case report of skin Kaposi's sarcoma Hunan Yi Ke da Xue Xue Bao 27(6): 562 566
Ragimov, A.A.; Dashkova, N.G.; Nazarli, A.G.; Zeĭnalova, A.A.; Efendieva, E.G. 1986: Effect of blood transfusions on the indices of immunity and iron metabolism in patients with different forms of thalassemia Gematologiia i Transfuziologiia 31(11): 14-18
Rodionov, S.V. 1977: Cellular immunity indices in osteogenic sarcoma Voprosy Onkologii 23(11): 18-23
Simonart, T.; Dobbeleer, G.D.; Peny, M.; Fayt, I.; Parent, D.; Vooren, J.; Noel, J. 1999: Pre-Kaposi's sarcoma: an expansion of the spectrum of Kaposi's sarcoma lesions European Journal of Dermatology: Ejd 9(6): 480-482
Sherbakova, I.V.; Siriachenko, T.M.; Sarmanova, Z.V.; Kaleda, V.G.; Barkhatova, A.N.; Lideman, R.R.; Kliushnik, T.P. 2005: Some indices of congenital and acquired immunity in patients with endogenous diseases of schizophrenic spectrum disorders Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 105(5): 47-51
Gorczynski, R.M. 1974: Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals Journal of Immunology 112(5): 1826-1838